PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 29910179-3 2018 Here we report the use of CD19-targeted CAR T cells incorporating the intracellular signaling domain of CD28 (19-28z) as a consolidative therapy in 8 patients with residual CLL following first-line chemoimmunotherapy with pentostatin, cyclophosphamide, and rituximab. Pentostatin 222-233 CD28 molecule Homo sapiens 104-108